Arthritis Clinical Trials in Arizona

39 recruiting studies across 3 cities

Browse by City

Mesa

All Trials in Arizona

Phase

Trial	Phase	Sponsor	Dist.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	<1 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	<1 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease	Phase 3	Vor Biopharma	<1 mi
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement	—	More Foundation	<1 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	<1 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee	Phase 2	Pacira Pharmaceuticals, Inc	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	<1 mi
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis	Phase 1	Eli Lilly and Company	<1 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	<1 mi
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain	Phase 2	Eli Lilly and Company	<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/3	Olatec Therapeutics, Inc.	<1 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	3 mi
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)	Phase 2	Elevara Medicines Limited	3 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	3 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	3 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	Phase 2	Merck Sharp & Dohme LLC	3 mi
A Study of AZD0120 in Autoimmune Diseases	Phase 1	AstraZeneca	3 mi
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis	Phase 3	Takeda	3 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis	Phase 3	Medipost, Inc.	5 mi
FX Shoulder Solutions Retrospective / Prospective Clinical Study	—	FX Shoulder Solutions	5 mi
FX Shoulder Prospective Clinical Study	—	FX Shoulder Solutions	5 mi
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis	Phase 1	Sonoma Biotherapeutics, Inc.	8 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain	Phase 1	R3 Stem Cell	8 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis	Early 1	R3 Medical Research	8 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases	Phase 2	Amgen	8 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)	Phase 2	Hoffmann-La Roche	13 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare	Phase 2	Atom Therapeutics Co., Ltd	13 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	13 mi
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden	Phase 3	Novartis Pharmaceuticals	13 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.